Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma

Cancer

Volumn 121, Issue 18, 2015, Pages 3252-3260

  Smith, Franz O ^a   Yue, Binglin ^a   Marzban, Suroosh S ^b   Walls, Brooke L ^c   Carr, Michael ^b   Jackson, Ryan S ^b   Puleo, Christopher A ^a   Padhya, Tapan ^b   Cruse, C Wayne ^a   Gonzalez, Ricardo J ^a   Sarnaik, Amod A ^a   Schell, Michael J ^a   Deconti, Ronald C ^a   Messina, Jane L ^a   Sondak, Vernon K ^a   Zager, Jonathan S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Merkel cell carcinoma; sentinel lymph node; survival; tumor depth; tumor diameter

Indexed keywords

AGED; CANCER RECURRENCE; CANCER STAGING; CONFERENCE PAPER; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; TUMOR DEPTH; TUMOR DIAMETER; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MORTALITY; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

AGED; CARCINOMA, MERKEL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84940924700     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29452     Document Type: Conference Paper

References (30)

1. Toker C,. Trabecular carcinoma of the skin. Arch Dermatol. 1972; 105: 107-110.
2. Moll R, Lowe A, Laufer J, et al., Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992; 140: 427-447.
3. Hughes MP, Hardee ME, Cornelius LA, et al., Merkel cell carcinoma: epidemiology, target, and therapy. Curr Dermatol Rep. 2014; 3: 46-53.
4. Santamaria-Barria JA, Boland GM, Yeap BY, et al., Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol. 2013; 20: 1365-1373.
5. Allen PJ, Bowne WB, Jaques DP, et al., Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005; 23: 2300-2309.
6. Hui AC, Stillie AL, Seel M, et al., Merkel cell carcinoma: 27-year experience at the Peter MacCallum Cancer Centre. Int J Radiat Oncol Biol Phys. 2011; 80: 1430-1435.
7. Fields RC, Busam KJ, Chou JF, et al., Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg. 2011; 254: 465-473.
8. Lemos BD, Storer BE, Iyer JG, et al., Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010; 63: 751-761.
9. Ortin-Perez J, van Rijk MC, Valdes-Olmos RA, et al., Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma. Eur J Surg Oncol. 2007; 33: 119-122.
10. National Comprehensive Cancer Network. Merkel cell carcinoma (version 1.2015). http://www.nccn.org/professionals/physician-gls/pdf/mcc.pdf. Accessed April 4, 2015.
11. Miller SJ, Alam M, Andersen J, et al., Merkel cell carcinoma. J Natl Compr Canc Netw. 2009; 7: 322-332.
12. Fields RC, Busam KJ, Chou JF, et al., Recurrence and survival in patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol. 2011; 18: 2529-2537.
13. Koljonen V, Tukiainen E, Haglund C, et al., Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma. Histopathology. 2006; 49: 551-553.
14. Goldberg SR, Neifeld JP, Frable WJ,. Prognostic value of tumor thickness in patients with Merkel cell carcinoma. J Surg Oncol. 2007; 95: 618-622.
15. Sandel HDT, Day T, Richardson MS, et al., Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope. 2006; 116: 791-795.
16. Andea AA, Coit DG, Amin B, et al., Merkel cell carcinoma: histologic features and prognosis. Cancer. 2008; 113: 2549-2558.
17. Llombart B, Monteagudo C, Lopez-Guerrero JA, et al., Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology. 2005; 46: 622-634.
18. Heath M, Jaimes N, Lemos B, et al., Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008; 58: 375-381.
19. Albores-Saavedra J, Batich K, Chable-Montero F, et al., Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010; 37: 20-27.
20. Gupta SG, Wang LC, Penas PF, et al., Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006; 142: 685-690.
21. Schwartz JL, Griffith KA, Lowe L, et al., Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol. 2011; 29: 1036-1041.
22. Stokes JB, Graw KS, Dengel LT, et al., Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol. 2009; 27: 3772-3777.
23. Bajetta E, Celio L, Platania M, et al., Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann Surg Oncol. 2009; 16: 2985-2993.
24. Warner RE, Quinn MJ, Hruby G, et al., Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol. 2008; 15: 2509-2518.
25. Hill AD, Brady MS, Coit DG,. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg. 1999; 86: 518-521.
26. Sarnaik AA, Zager JS, Cox LE, et al., Routine omission of sentinel lymph node biopsy for Merkel cell carcinoma <= 1 cm is not justified. J Clin Oncol. 2010; 28: e7.
27. Lim CS, Whalley D, Haydu LE, et al., Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma. Ann Surg Oncol. 2012; 19: 3325-3334.
28. Rao P, Balzer BL, Lemos BD, et al., Protocol for the examination of specimens from patients with Merkel cell carcinoma of the skin. Arch Pathol Lab Med. 2010; 134: 341-344.
29. Fields RC, Busam KJ, Chou JF, et al., Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer. 2012; 118: 3311-3320.
30. Asgari MM, Sokil MM, Warton EM, et al., Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol. 2014; 150: 716-723.